In the grand theater of cellular biology, where proteins perform their ancient choreography and genes conduct their molecular symphonies, a new player has emerged from the most unexpected corner...
Fantastic deep dive into MOTS-c. The most compelling insight is how this peptide flips the traditional understanding of mitocohndrial function from passive energy producers to active communicators. The 30-minute nuclear translocation under stress is genuinely impressive timing for a cellular messenger. I've been tracking peptide therapies for a while and the early ME/CFS trial data looks promising, tho the real test will be whether it can address the underlying mitochondrial dysfunction or just mask symptoms.
Fantastic deep dive into MOTS-c. The most compelling insight is how this peptide flips the traditional understanding of mitocohndrial function from passive energy producers to active communicators. The 30-minute nuclear translocation under stress is genuinely impressive timing for a cellular messenger. I've been tracking peptide therapies for a while and the early ME/CFS trial data looks promising, tho the real test will be whether it can address the underlying mitochondrial dysfunction or just mask symptoms.
That last one is a great point. Do you know of any particular research labs engaged in longitudinal studies currently?